Identification of identical BAP1 mutations in a patient's peritoneal mesothelioma and mucosal melanoma: A precision medicine case study
Biomarker testing has increasingly been adopted in oncology for diagnostic, prognostic, and predictive purposes. Several tumor types undergo reflexive biomarker testing, including immunohistochemistry and next generation sequencing (NGS), to screen for hereditary tumor predisposition syndromes and i...
Saved in:
Main Authors: | Paul Zamiara (Author), Ibrahim Elsharawi (Author), Daniel Gaston (Author), Ryan C. DeCoste (Author), Eoghan Malone (Author), Martin J. Bullock (Author), Mathieu C. Castonguay (Author), Michael D. Carter (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peritoneal malignant psammomatous mesothelioma
by: Teresa Pusiol, et al.
Published: (2011) -
An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome
by: Kelly Z. Young, BA, et al.
Published: (2020) -
Advances in diffuse malignant peritoneal mesothelioma
by: Tristan D. Yan, et al.
Published: (2011) -
Advances in diffuse malignant peritoneal mesothelioma
by: Tristan D. Yan, et al.
Published: (2011) -
Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma
by: Matthew Yen, et al.
Published: (2018)